Topics › Health Sciences › Medicine › Gastroenterology
Gastrointestinal Tumor Research and Treatment Sign in to save
Papers per year
Papers 77
Open in paper search →-
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial2020 The Lancet Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access cited by 48 patents
Jean‐Yves Blay, César Serrano, Michael Charles Heinrich, John Raymond Zalcberg, Sebastian Bauer, Hans A. J. Gelderblom, +11 more
430citations -
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial2022 Journal of Clinical Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access
Sebastian Bauer, Robin L. Jones, Jean‐Yves Blay, Hans A. J. Gelderblom, Suzanne George, Patrick Schöffski, +13 more
121citations -
Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib
Alessandro Gronchi, Sylvie Bonvalot, Andrés Poveda Velasco, Dusan Kotasek, Piotr Lukasz Rutkowski, Peter Hohenberger, +18 more
96citations -
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib2020 Journal of Clinical Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access
Filip Jankú, Albiruni R. Abdul Razak, Ping Chi, Michael Charles Heinrich, Margaret von Mehren, Robin L. Jones, +10 more
91citations -
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆
Paolo Giovanni Casali, Axel Le Cesne, Andrés Poveda Velasco, Dusan Kotasek, Piotr Lukasz Rutkowski, Peter Hohenberger, +15 more
75citations -
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST’
Patrick Schöffski, Olivier Mir, Bernd Kasper, Zsuzsanna Pápai, Jean‐Yves Blay, Antoîne Italiano, +15 more
72citations -
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study2021 Clinical Cancer Research article Medicine Gastrointestinal Tumor Research and Treatment Open access
Bruno Vincenzi, Andrea Napolitano, Marta F. Fiocco, Olivier Mir, Piotr Lukasz Rutkowski, Jean‐Yves Blay, +31 more
47citations -
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study2021 Clinical Cancer Research article Medicine Gastrointestinal Tumor Research and Treatment Open access
Sebastian Bauer, Michael Charles Heinrich, Suzanne George, John Raymond Zalcberg, César Serrano, Hans A. J. Gelderblom, +11 more
46citations -
Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort2020 European Journal of Surgical Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access
Nikki S. IJzerman, Mahmoud Mohammadi, Dimitri Tzanis, Hans A. J. Gelderblom, Marco Fiore, Elena R. Fumagalli, +15 more
42citations -
Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour2021 European Journal of Cancer article Medicine Gastrointestinal Tumor Research and Treatment Open access
Suzanne George, Ping Chi, Michael Charles Heinrich, Margaret von Mehren, Robin L. Jones, Kristen N. Ganjoo, +11 more
31citations -
Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study2020 British Journal of Cancer article Medicine Gastrointestinal Tumor Research and Treatment Open access
Hans A. J. Gelderblom, Robin L. Jones, Suzanne George, Claudia Valverde Morales, Charlotte Benson, Jean‐Yves Blay, +8 more
24citations -
INTRIGUE: A phase III, randomized, open-label study to evaluate the efficacy and safety of ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib2022 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Michael Charles Heinrich, Robin L. Jones, Hans A. J. Gelderblom, Suzanne George, Patrick Schöffski, Margaret von Mehren, +13 more
18citations
Most active Aachen authors
-
Hans A. J. Gelderblom 55,175 citations overall66 papers
-
Mahmoud Mohammadi 264 citations overall13 papers
-
Judith V.M.G. Bovée 26,162 citations overall5 papers
-
Jos A. van der Hage 8,375 citations overall5 papers
-
Henk H. Hartgrink 5,532 citations overall5 papers
-
Lioe‐Fee de Geus‐Oei 11,683 citations overall4 papers
-
Marta F. Fiocco 14,470 citations overall3 papers
-
Gijsbert M. Kalisvaart 104 citations overall3 papers
-
Aart J. van der Molen 5,955 citations overall2 papers
-
Dirk Jan A. R. Moes 4,889 citations overall2 papers
-
Yvonne M. Schrage 1,775 citations overall2 papers
-
Willem Grootjans 714 citations overall2 papers
-
Suk Wai Lam 573 citations overall2 papers
-
H. Gelderblom 25 citations overall2 papers
-
Ylva Weeda 15 citations overall2 papers